The Innovation of Wearable Technology and Medical Devices

Friday, October 14, 2016 Medical Gadgets J E 4

NEW YORK, October 14, 2016 /PRNewswire/ --

October 14, 2016 - A major development in the wearable technology and devices market is quickly becoming popular. According to a research report conducted by Transparency Market Research indicates that the wearable devices market, or the remote patient monitoring devices market, is anticipated to reach US$0.98 billion by the end of 2020. This represents a growth of 14.2% CAGR rate. Biotricity Inc. (OTC: BTCY), Abbott Laboratories (NYSE: ABT), Apple (NASDAQ: AAPL), Alphabet (NASDAQ: GOOGL), Business Machines Corp. (NYSE: IBM)

Remote patient monitoring is the latest innovation in the healthcare industry, as it allows patients to keep a check on their own conditions, eliminating the need for repeated visits to the physician's office. The precision of such devices have the potential to improve diagnosis, and a more customized treatment or post-treatment recuperative plan. The most significant growth drivers for the markets are the growing role these devices will play in diagnosis and treatment plans of chronic diseases such as diabetes, arthritis, and osteoporosis.

While most companies try to appeal to various segments of the wearable devices markets, some made innovations in the healthcare industry to help physicians better monitor patient goals. A small company in the heart of this sector, Biotricity Inc. (OTCQB: BTCY) is focusing on biometric monitoring solutions for medical, healthcare and consumer use. The company has two devices which are expected to be launched into the market by the end of this year, Bioflux and Biolife.

Bioflux includes an ECG (heart-rhythm) monitoring device, software and access to a monitoring lab. The software component is already FDA approved and a standard for ECG monitoring in hospitals and cardiac clinics. Bioflux is by all means, a medical wearable device, and is only available with a prescription. Biotricity Inc. (BTCY) explains that it performs remote MCT diagnostic monitoring for up to 30 consecutive days and is a solution that enables physicians to diagnose Cardiovascular Disease (CVD) or Coronary Heart Disease (CHD).

Biolife is a much more easily accessible device. According to Biotricity Inc. (BTCY) it is designed to provide health and lifestyle solutions by monitoring ECG, respiration rate, calories, temperature, physical activity and more. The product is currently in development stages and will be ready to hit the market in the near future. Essentially, Biolife is a medical device designed to facilitate disease management, example Cardiovascular monitoring.

Abbott Laboratories (NYSE: ABT) is engaged in the discovery, development, manufacture and sale of a line of healthcare products, including diagnostic products and medical devices. Joel Goldsmith who is a Senior Director of New Product Innovation of Abbott, has spoken about the importance of wearables in the medical field, and how it changes the environment of the workforce. "The introduction of wearables as a category-plus the startups fueled by the growing awareness of mobile and consumer health technology-has changed the game. A lot of what we do looks more similar to a mobile app company than a traditional medical device company." Goldsmith said.

This merge between medical devices and advanced mobile technology has created need for new talent. The new talent that wearable medical devices already bring into the medical industry and their influence was also noted by Abbott's vice president of Abbott Global Talent Acquisition, who said, "Increasingly, new types of expertise are in demand, including informatics, software engineering, and digital data strategy."

It is not surprising then that tech industry giants like Apple (NASDAQ: AAPL), Alphabet (NASDAQ: GOOGL), and International Business Machines Corp. (NYSE: IBM) are increasingly moving into the healthcare and medical arena. These companies have major resources and the talent needed to change the direction of the industry. This August for example, Apple has revealed that it has a new patent application with the US Patent and Trademark Office, according to which Apple wants to own a new wearable health device that could be fashioned into different accessories. It could be a watch, a ring, a brooch or something else entirely. 

Subscribe Now! Watch us report from NYSE

For "The Latest Buzz in Financial News", SIGN UP & Visit:

Follow us on Twitter for real time Financial News Updates:

Follow and talk to us on Instagram:

Facebook Like Us to receive live feeds:

About, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, creates 100% unique original content. also provides financial news PR branding, marketing and advertising for third parties for disseminating news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.

Please Note: is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on (the "Site") is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content),, a financial news media and pr marketing firm enters into service agreements with the companies which are the subject to the articles posted on the Site for advertising such companies. has signed a four month financial news pr services agreement for ten thousand dollars directly from the biotricity inc. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. receives fees for producing and presenting high quality and sophisticated content on this site along with other financial news pr media services. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. agreed to a four month financial news pr services agreement for ten thousand restricted shares and twenty thousand warrants directly from biotricity inc. does not undertake to update any of the information on the Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security., members and affiliates are not responsible for any gains or losses that result from the opinions expressed on the Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. By accessing this website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use. Please visit:

For further information:

Media Contact: Danny A,, +1-877-601-1879




You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Brain Thrive by 25 Improves Overall Brain Function...
CHMP Adopts Positive Opinion of Metformin, Includi...